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Disrupted Brain Circuitry for
Pain-Related Reward/Punishment in Fibromyalgia
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Ajay D. Wasan,3 Richard E. Harris,4 Robert R. Edwards,3 and Vitaly Napadow1
Objective. While patients with fibromyalgia (FM)
are known to exhibit hyperalgesia, the central mecha-
nisms contributing to this altered pain processing are
not fully understood. This study was undertaken to
investigate potential dysregulation of the neural cir-
cuitry underlying cognitive and hedonic aspects of the
subjective experience of pain, such as anticipation of
pain and anticipation of pain relief.
Methods. Thirty-one FM patients and 14 controls
underwent functional magnetic resonance imaging,
while receiving cuff pressure pain stimuli on the leg
calibrated to elicit a pain rating of 50 on a 100-point
scale. During the scan, subjects also received visual cues
informing them of the impending onset of pain (pain
anticipation) and the impending offset of pain (relief
anticipation).
Results. Patients exhibited less robust activation
during both anticipation of pain and anticipation of
relief within regions of the brain commonly thought to
be involved in sensory, affective, cognitive, and pain-
modulatory processes. In healthy controls, direct
searches and region-of-interest analyses of the ventral
tegmental area revealed a pattern of activity compatible
with the encoding of punishment signals: activation
during anticipation of pain and pain stimulation, but
deactivation during anticipation of pain relief. In FM
patients, however, activity in the ventral tegmental area
during periods of pain and periods of anticipation (of
both pain and relief) was dramatically reduced or
abolished.
Conclusion. FM patients exhibit disrupted brain
responses to reward/punishment. The ventral tegmental
area is a source of reward-linked dopaminergic/-
aminobutyric acid–releasing (GABAergic) neurotrans-
mission in the brain, and our observations are compat-
ible with reports of altered dopaminergic/GABAergic
neurotransmission in FM. Reduced reward/punishment
signaling in FM may be related to the augmented
central processing of pain and reduced efficacy of opioid
treatments in these patients.
Fibromyalgia (FM) is a chronic, relatively com-
mon pain disorder characterized by persistent, wide-
spread body pain and myofascial tenderness, and it is
considered the quintessential functional pain disorder.
The prevalence of FM in the general US population is
estimated to be 3.4% in women and 0.5% in men, and it
increases with age (reaching 7% in women between
ages 60 and 79 years) (1). Some of the hallmarks of FM
include alterations of pain-modulatory processes in the
central nervous system, a prominent role of negative
affective factors in maintaining pain and disability, and a
poor enduring response to peripheral treatments such as
topical agents or trigger point injections, as well as
opioids (2). These characteristics highlight the central
nature of FM pathophysiology and have been the basis
for several brain imaging studies of this disorder. Col-
lectively, evidence derived from psychophysical and
functional neuroimaging studies supports the notion of
Supported by the National Center for Complementary and
Alternative Medicine, NIH (grants R01-AT-004714, P01-AT-002048,
P01-AT-006663, R01-AT-005280, R01-AG-034982, and R21-AR-
057920).
1Marco L. Loggia, PhD, Vitaly Napadow, PhD: Massachu-
setts General Hospital, Brigham and Women’s Hospital, and Harvard
Medical School, Boston, Massachusetts; 2Chantal Berna, MD, PhD,
Jieun Kim, PhD, Randy L. Gollub, MD, PhD: Massachusetts Gen-
eral Hospital and Harvard Medical School, Boston, Massachusetts;
3Christine M. Cahalan, BS, Ajay D. Wasan, MD, MSc, Robert R.
Edwards, PhD: Brigham and Women’s Hospital and Harvard Medical
School, Boston, Massachusetts; 4Richard E. Harris, PhD: University of
Michigan, Ann Arbor.
Drs. Edwards and Napadow contributed equally to this work.
Dr. Harris has received consulting fees, speaking fees, and/or
honoraria (less than $10,000), as well as grant support, from Pfizer.
Address correspondence to Marco L. Loggia, PhD, Massa-
chusetts General Hospital, 149 13th Street, Suite 2301, Charlestown,
MA 02129. E-mail: marco@nmr.mgh.harvard.edu.
Submitted for publication February 27, 2013; accepted in
revised form September 3, 2013.
203
augmented sensitivity to painful stimulation in FM,
which is thought to be due predominantly to aberrant
brain processing of pain-related information (2,3).
However, while the neural correlates of experi-
mental pain (4–6) and clinical pain (7) in FM have been
the subject of several investigations, potential dysregu-
lation of the neural mechanisms underlying anticipation
of pain and anticipation of pain relief in this population
of patients with chronic pain has received little attention.
This is an important distinction, since cognitive, motiva-
tional, and affective processes have been shown to be
intimately involved in the perception and reporting of
pain, including in patients with FM (3,8,9). Importantly,
the state of the brain preceding painful stimulation has
been shown to predict responses to experimental pain
(10), as well as clinical pain (11). Expectancy and
pain-relevant anxiety, in particular, have been shown to
shape subsequent perceptual states (12). Relief from
pain, on the other hand, is a positive hedonic experience
intrinsically linked to pain (13). It has been suggested
that the experience of relief may be altered in patients
with chronic pain (14). Since pain and the anticipation of
both pain and relief have strong hedonic value linked to
their punishment/reward properties, it is reasonable to
suspect that these states may be processed differently in
FM patients, particularly in structures involved in the
encoding of appetitive or aversive stimuli.
In the present study of FM patients and controls,
we used functional magnetic resonance imaging (fMRI)
and cuff pain algometry to investigate brain responses to
deep tissue noxious stimulation, as well as responses to
anticipation of pain and anticipation of relief. We ad-
opted both a whole-brain approach and a region-of-
interest (ROI) approach focused on the nucleus accum-
bens and the ventral tegmental area, two mesolimbic
structures known to be involved in the processing of
reward/punishment (15) and implicated in FM patho-
physiology in positron emission tomography (PET)
studies (16,17).
PATIENTS AND METHODS
Subjects. Thirty-one FM patients and 14 healthy con-
trols were recruited to participate in this study. Enrolled
patients were diagnosed as having fibromyalgia (as confirmed
by physician and medical records) and met the recently
proposed American College of Rheumatology criteria (18),
which require the presence of widespread pain as well as a
number of somatic and cognitive symptoms. Healthy controls
were free of chronic pain and rheumatic disease. For both
groups, exclusion criteria included age 18 years, history of
significant psychiatric, neurologic, or cardiovascular disorders
or current diagnosis of the same, history of significant head
injury, current treatment with opioids, implanted medical or
metallic objects, and pregnancy. This study was approved by
the Partners Human Research Committee, and written in-
formed consent was obtained from all participants.
Study overview. Subjects participated in two separate
study visits on different days: a training visit (behavioral only)
and an imaging visit. The training session was used to famil-
iarize subjects with the stimuli and rating procedures and to
determine appropriate stimulus intensities to be used during
the subsequent imaging session.
Painful stimulation was achieved via cuff pain algom-
etry. We chose this technique over other more commonly used
methods of pain stimulation (e.g., contact heat) because cuff
pain stimuli appear to have a preferential effect on deep tissue
nociceptors (19). Since most clinical pain originates in deep
tissue rather than in cutaneous receptors, investigating brain
responses to deep tissue pain may prove to be more clinically
relevant than investigating brain responses to evoked cutane-
ous pain. As in our previous studies (20,21), mechanical stimuli
were delivered to the right calf using a 13.5-cm–wide Velcro-
adjusted pressure cuff, connected to a rapid cuff inflator (E20
AG101; Hokanson). The cuff inflator was adapted to ramp up
gradually to the target pressure over 2 seconds to minimize
abrupt motion in the subject.
After completing questionnaires (including the Beck
Depression Inventory, fatigue visual analog scale [VAS],
Widespread Pain Index, Short Form 36 health survey, and
Brief Pain Inventory), subjects were familiarized with the
procedures for cuff pain algometry. Subjects sat comfortably
on a chair with the left foot resting on a support at a slightly
elevated position. The vascular cuff was then secured around
the left gastrocnemius muscle. Quantitative sensory testing
began by inflating the cuff to 60 mm Hg of pressure and
making adjustments in 10–mm Hg increments until a pain
intensity rating of 50 on a 100-point scale was first obtained.
During the imaging visit, ratings of intensity and
unpleasantness of clinical pain (based on a VAS scale of
0–100) were obtained from patients. The stimulus pressure was
briefly recalibrated prior to scanning, using procedures similar
to those adopted during the training session. During a single
functional imaging scan run, brain activity was investigated
using blood oxygen level–dependent (BOLD) fMRI, while the
patient received 3 separate tonic cuff pain stimuli (of 46–74
seconds each) set to elicit the same pain intensity level (50 on
a 100-point scale) (Figure 1A).
Prior to each cuff inflation, a cross projected in the
subjects’ visual field changed from black to green to signal the
period of pain anticipation, and then turned black again at
stimulus onset. Prior to cuff deflation, the cross switched in
color from black to blue to signal the period of relief antici-
pation, and then turned black again at cuff stimulus offset.
These visual cues appeared for 6–12 seconds (i.e., jittered
in time). The use of relatively long pain stimuli was chosen
to maximize the emotional responses associated with expec-
tancy of pain and relief, and to ensure temporal separation
between regressors in the design matrix. For each of the 3 pain
blocks, 8 seconds after stimulus offset, subjects used a mag-
netic resonance–compatible button box to rate the intensity
and unpleasantness of the cuff pain stimuli on 0–100 electronic
scales (ePrime; Psychology Software Tools).
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Data from fMRI were acquired using a 3T Tim Trio
MRI system (Siemens) equipped for echo-planar imaging with
a 32-channel head coil. A whole brain T2*-weighted gradient-
echo BOLD echo-planar imaging pulse sequence was used
(repetition time [TR] 2 seconds, echo time [TE] 30 msec, flip
angle 90°, 32 anterior commissure–posterior commissure–
aligned axial slices, voxel size 3.1  3.1  4 mm). We also
collected anatomic data, using a multi-echo magnetization-
prepared rapid gradient-echo pulse sequence (TR 2,530 msec;
TE 1.64 msec, 3.5 msec, 5.36 msec, and 7.22 msec; flip angle 7°;
voxel size 1 mm [isotropic]).
Data analysis. All statistical analyses for behavioral
data were performed using Statistica 10.0 (StatSoft), with an
alpha level of 0.05. The significance of differences in the
distribution of the sexes between groups was assessed using
Fisher’s exact test. Deviation from normal was assessed using
the Kolmogorov-Smirnov test for all variables of interest: cuff
pressure values (i.e., pressure values, expressed as millimeters
of mercury, eliciting the target pain intensity rating of 50 on
a 100-point scale in the recalibration performed at the begin-
ning of the imaging visit) and mean intensity and unpleasant-
ness ratings (averaged over 3 trials). Since distribution of cuff
pressure values in both patients and controls and distribution
of pain intensity ratings in controls significantly deviated from
normal (P  0.05), all group comparisons were performed
using the nonparametric Mann-Whitney U test. Group analy-
ses were performed to compare cuff pressure values (to
determine differences in pain sensitivity between FM patients
and controls) and pain ratings (to assess successful calibration
of cuff pressure and possible differences in the affective
responses associated with the stimulus) for both pain intensity
and unpleasantness separately, averaged across the 3 trials.
Functional MRI data were processed using FMRI
Expert Analysis Tool version 5.98, which is part of Functional
Magnetic Resonance Imaging of the Brain (FMRIB) Software
Library (FSL) (online at www.fmrib.ox.ac.uk/fsl) (22). Data
underwent the following preprocessing: motion correction,
field map–based echo-planar imaging unwarping, nonbrain
removal, spatial smoothing (full-width half-maximum of 5
mm), grand mean intensity normalization by a single multipli-
cative factor, and high-pass temporal filtering (Gaussian-
weighted least-squares straight-line fitting [  72 seconds]).
Time-series statistical analysis was performed using FMRIB’s
Improved Linear Model with local autocorrelation correction.
Cortical surface reconstruction (23) was performed using
FreeSurfer software (online at http://surfer.nmr.mgh.
harvard.edu/) for improved structural/functional coregistration
purposes. A recently developed automated boundary-based
registration algorithm (FreeSurfer’s bbregister tool) was used
for coregistration. Scans were registered to the Montreal
Neurological Institute (MNI) template MNI152 standard
space using FMRIB’s Linear Image Registration Tool.
Our first-level within-subject general linear model ana-
lysis included the pain expectancy cue, cuff pain stimulus
application, and the expectancy of pain relief cue as regressors
of interest. We also modeled the period between stimulus
offset and the rating periods, as well as the rating periods, as
regressors of no interest. A canonical double-gamma hemody-
namic response function was adopted. Parameter estimates
and relative variances for each explanatory variable were then
included in mixed-effects group level analyses, performed
using FMRIB’s Local Analysis of Mixed Effects 12, with
enabled automatic outlier detection. Whole-brain statistical
parametric maps were computed for the following regressors:
pain anticipation, pain stimulus, and relief anticipation.
Thresholds were set for all maps using clusters determined
using a voxelwise threshold (Z  2.3) and a (corrected) cluster
significance threshold (P  0.05).
Group comparisons of brain responses to pain antici-
pation, pain, and relief anticipation were also performed with
a direct search restricted to the nucleus accumbens and the
ventral tegmental area. Direct searches of the nucleus accum-
bens were performed within the labels from the Harvard–
Oxford Subcortical Structural Atlas (online at http://
www.cma.mgh.harvard.edu/fsl_atlas.html), and threshold was
set at a (arbitrary) value of 80 (size of the right nucleus
accumbens mask 11 voxels; size of the left nucleus accumbens
mask 14 voxels) (data available upon request from the corre-
sponding author). The direct search of the ventral tegmental
Figure 1. A, Experimental design of the study. Each patient with
fibromyalgia (FM) and each control subject underwent cuff pain
stimuli 3 times, while brain response was recorded using functional
magnetic resonance imaging. Ratings of pain intensity (int.) and pain
unpleasantness (unpl.) were obtained from patients. A cross projected
in the subjects’ visual field changed from black to green to signal the
period of pain anticipation (anticip.). The cross switched from black to
blue to signal the period of pain relief anticipation. B, Cuff pressure
needed to induce the target pain rating (left) and pain intensity rating
(right). Values are the median and interquartile range.   P  0.01.
NS  not significant.
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area was performed within an anatomically defined mask
manually drawn on the MNI152 brain at a resolution of 0.5
mm, based on its location medial to the substantia nigra and
the red nuclei (size of the right ventral tegmental area 77
voxels; size of the left ventral tegmental area 81 voxels) (24).
The correct coregistration between each of these masks and
each subject’s spatially normalized fMRI maps was confirmed
by visual inspection. These direct searches were performed
with an uncorrected threshold value (Z  2.58) and a mini-
mum cluster size (5 voxels). From these regions, mean Z
statistic values were extracted to create correlational plots,
as well as to display group differences (for illustrative pur-
poses). In order to further corroborate the significant results
obtained from the ventral tegmental area direct searches, an
ROI analysis was performed by averaging the Z score from all
the voxels within the ventral tegmental area mask (split into
left and right). An unpaired t-test with an alpha level of 0.05
was performed to compare average ventral tegmental area Z
scores across groups, Statistica 10.0.
RESULTS
Psychophysical results. Demographic and clini-
cal data are presented in Table 1. There was no statis-
tically significant between-group difference for sex dis-
tribution (P  0.23). Prior to scanning, FM patients
reported the intensity of their current clinical pain as a
mean  SD of 34.3  25.19 on a 100-point scale (range
0–78) and unpleasantness of their pain as 32.3  26.7
(range 0–90). Ratings of intensity and unpleasantness of
clinical pain were highly correlated (r  0.88, P 
0.0001). In patients, baseline clinical pain ratings tended
to be negatively correlated with cuff pressure values that
were selected to elicit a target rating of 50 on a 100-point
scale (clinical pain intensity [r  0.33, P  0.071],
clinical pain unpleasantness [r  0.35, P  0.051]). As
shown in Figure 1B, there was no statistically significant
difference between FM patients and controls in the pain
intensity ratings elicited by the cuff pressure (and the
same was observed for the unpleasantness ratings) (all
P  0.30). This was expected due to percept-matched
calibration. However, the pressure needed to induce the
target pain rating was significantly lower in FM patients
than in controls (P  0.01).
Imaging results—whole brain analyses. In both
groups the pain anticipation cue (Figure 2 and Supple-
mentary Table 1, available on the Arthritis & Rheuma-
tology web site at http://onlinelibrary.wiley.com/doi/
10.1002/art.38191/abstract) elicited activation in
multiple regions of the brain, including the primary
somatosensory and motor cortices, the supplementary
motor area, the dorsolateral prefrontal cortex, the sec-
ondary somatosensory cortex, the posterior cingulate
cortex, the middle cingulate cortex, the subgenual ante-
rior cingulate cortex, the superior parietal lobule, the
insula/frontal operculum, the periaqueductal gray, the
basal ganglia, the medial and lateral visual areas, the
parahippocampal gyrus, and the cerebellum. Control
subjects experienced significantly stronger brain re-
sponses to pain anticipation in several of these regions,
including the supplementary motor area, the middle
cingulate cortex, the posterior cingulate cortex, the
periaqueductal gray, the ventral tegmental area and
visual cortices bilaterally, the caudate nucleus (head)
and the globus pallidus on the left, and the secondary
somatosensory cortex and posterior insula on the right.
Patients did not exhibit a stronger BOLD response to
pain anticipation in any region compared to controls.
In both groups, cuff pain stimuli evoked brain
activity changes in regions frequently observed as acti-
vated or deactivated during experimental pain (Figure 3
and Supplementary Table 2, available on the Arthritis &
Rheumatology web site at http://onlinelibrary.wiley.com/
doi/10.1002/art.38191/abstract). Activated regions in-
cluded the thalamus, the insula/frontal operculum, the
secondary somatosensory cortex, the dorsolateral pre-
frontal cortex, the basal ganglia, and the cerebellum.
Medial and lateral visual cortices were also activated.
Deactivations were observed in the medial prefrontal
cortex in both groups. No group differences were ob-
served in the whole-brain analyses for pain-induced
brain activity.
The visual cue for relief anticipation (Figure 4






Age, years 44.2  14.3 44.0  11.9
Sex, % female 71.4 87.1
Symptom duration, years – 12.5  12.2
Clinical pain, 0–100 scale
Intensity – 34.3  25.19
Unpleasantness – 32.3 26.7
Fatigue, 0–100 scale 13.0  16.4 64.6  22.3†
BDI, 0–63 scale 2.8  3.8 17.0  13.6†
WPI, no. of pain sites of
a possible 19
0.4  0.8 11.6  8.1†
SF-36, 0–100 scale
General health 88.6  13.8 39.0  23.7†
Physical function 90.4  26.4 47.4  26.0†
BPI, 0–10 scale
Pain interference 0.0 0.0 5.5  2.0†
Pain severity 0.3 0.6 5.3  2.0†
* Except where indicated otherwise, values are the mean  SD. FM 
fibromyalgia; BDI  Beck Depression Inventory; WPI Widespread
Pain Index; SF-36  Short Form 36 health survey; BPI  Brief Pain
Inventory.
† P  0.001 versus controls.
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and Supplementary Table 3, available on the Arthritis &
Rheumatology web site at http://onlinelibrary.wiley.com/
doi/10.1002/art.38191/abstract) produced significant ac-
tivations in the primary somatosensory and motor cor-
tices, the lateral and medial prefrontal cortices, the
operculo-insular cortex, the precuneus, and visual areas
in both groups. In controls, stronger BOLD responses
were observed in the left primary somatosensory and
motor cortices (sensorimotor representation of the
leg), superior parietal lobule, dorsolateral prefrontal
cortex, ventrolateral prefrontal cortex, and operculo-
insular cortices compared to patients. In the whole-brain
analyses, FM patients did not exhibit a stronger BOLD
response to the expectancy of pain relief cue in any
region compared to controls.
Figure 3. Responses in the brain to pain (whole-brain analyses).
Responses were measured in controls (A) and fibromyalgia (FM)
patients (B), and activation was measured in FM patients versus
controls (C). In whole-brain searches, there was no statistically signif-
icant difference (NS) in the response to cuff pain between the 2
groups. S2 secondary somatosensory cortex; VLPFC ventrolateral
prefrontal cortex; MPFC  medial prefrontal cortex; dACC  dorsal
anterior cingulate cortex. Color figure can be viewed in the online
issue, which is available at http://onlinelibrary.wiley.com/
doi/10.1002/art.38191/abstract.
Figure 2. Responses in the brain to pain anticipation (whole-brain
analyses). Responses were measured in controls (A) and fibromyalgia
(FM) patients (B), and activation was measured in FM patients versus
controls (C). FM patients exhibited lower activity in the brain in
several regions. S1/M1  primary somatosensory/motor cortices;
SMA  supplementary motor area; MCC  middle cingulate area;
sgACC subgenual anterior cingulate cortex; VTA ventral tegmen-
tal area; PAG  periaqueductal gray; DLPFC  dorsolateral prefron-
tal cortex. Color figure can be viewed in the online issue, which is
available at http://onlinelibrary.wiley.com/doi/10.1002/art.38191/
abstract.
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Imaging results—ventral tegmental area and nu-
cleus accumbens analyses. No group differences reached
statistical significance for the nucleus accumbens in the
direct searches. In the right ventral tegmental area, a
voxelwise direct search revealed group differences in all
3 statistical comparisons (Figure 5). Healthy controls
exhibited an increase in BOLD signal during pain antic-
ipation and pain stimulation, but a decrease during relief
anticipation. In FM patients, however, these responses
were either significantly reduced (pain), or null (pain
anticipation and relief anticipation) (Figure 5B).
Figure 5. Direct searches in the ventral tegmental area (VTA). A, For
the analysis of regions of interest, the ventral tegmental area mask
(left) was drawn in the midbrain, medial to the substantia nigra and
ventral to the red nucleus (right). Adapted, with permission, from ref.
24. B, There was a statistically significant reduction in responses
(activations or deactivations) to anticipation of pain, pain, and antic-
ipation of pain relief in the ventral tegmental area of fibromyalgia
(FM) patients compared to controls. Bars show the mean  SEM. C,
Responses to pain anticipation were negatively correlated with re-
sponses to relief anticipation in the ventral tegmental area in controls,
but not in FM patients.
Figure 4. Responses in the brain to anticipation of pain relief (whole-
brain analyses). Responses were measured in controls (A) and fibro-
myalgia (FM) patients (B), and activation was measured in FM
patients versus controls (C). FM patients exhibited lower brain re-
sponses in several regions of the brain. SPL superior parietal lobule;
S1/M1  primary somatosensory/motor cortices; DLPFC  dorsolat-
eral prefrontal cortex; VLPFC  ventrolateral prefrontal cortex.
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Similar results were observed in ROI analyses
that averaged the values from all voxels in the right
ventral tegmental area mask. Compared to FM patients,
control subjects exhibited stronger activations during
pain anticipation (P 0.01) and a trend toward stronger
activations during pain stimulus (P  0.059), while
stronger deactivations were found during relief antici-
pation (P  0.05). Using the left ventral tegmental area
as an ROI, no statistically significant group differences
were observed during pain stimulation or during antici-
pation of relief, similar to the findings of the direct
search (P  0.6). However, the left ventral tegmental
area did reveal a statistically significant difference in the
BOLD signal between FM patients and controls in
regard to pain anticipation (i.e., control subjects had a
stronger BOLD signal) (P  0.05). In the ventral
tegmental area subregion showing statistically significant
group differences in all comparisons, responses to pain
anticipation were positively correlated with responses to
pain in both groups (control subjects [r  0.54, P 
0.048], FM patients [r  0.55, P  0.001]). Responses in
the ventral tegmental area to pain anticipation were also
negatively correlated with responses in the ventral teg-
mental area to relief anticipation in the control subjects
(r  0.76, P  0.002), but not in the FM patients (r 
0.12, P  0.52) (Figure 5C).
DISCUSSION
Our evidence indicates differences between FM
patients and controls in brain processing during pain, as
well as during anticipation of pain and of pain relief.
During pain anticipation (Figure 2), multiple regions
were activated in healthy controls, (including the ante-
rior cingulate cortex, the periaqueductal gray, the thal-
amus, the premotor cortex, and the ventral tegmental
area, i.e., areas previously reported as being associated
with expectancy of pain [25]), as well as other regions
thought to be involved in sensory, affective, cognitive,
and pain-modulatory processes (such as the primary
somatosensory and motor cortices, the secondary so-
matosensory cortex, the dorsolateral prefrontal cortex,
the fronto-insular cortex, and the basal ganglia) (26).
Interestingly, brain responses to pain anticipation were
significantly reduced in FM patients.
Cuff pain stimuli (Figure 3) evoked brain activity
changes in regions frequently observed to be activated
(the thalamus, the insula/frontal operculum, the second-
ary somatosensory cortex, the dorsolateral prefrontal
cortex, the basal ganglia, and the cerebellum) or deac-
tivated (medial prefrontal cortex) during experimental
pain (21,26). These brain activity changes were statisti-
cally indistinguishable between groups in whole-brain
analyses. Of note, we were able to observe these brain
responses even if the stimuli were delivered for a longer
duration (i.e., 46–74 seconds) than that used in most
published fMRI pain studies. Still, the lack of activation
within the primary somatosensory cortex (which con-
trasts with the presence of primary somotosensory cor-
tex activations that we have previously observed with
cuff pain stimuli of shorter duration [21]) could be due
to the length of stimulation.
During the relief anticipation period (Figure 4),
visual areas were similarly activated in both groups
(likely in response to the processing of the visual cue).
However, FM patients exhibited lower brain activa-
tions compared to controls in multiple regions, including
the primary somatosensory and motor cortices, superior
parietal lobule, ventro- and dorsolateral prefrontal and
fronto-insular cortices. Overall, these results add to the
growing body of literature supporting the notion that
FM patients demonstrate reduced responsiveness to a
variety of experimental manipulations (4,27,28).
Analyses (direct search and ROI) that were fo-
cused on mesolimbic regions revealed group differences
in responses to pain anticipation, pain, and relief antic-
ipation in the right ventral tegmental area (Figure 5).
The ventral tegmental area is a dopamine-rich region
that occupies the ventromedial portion of the midbrain.
While dopaminergic neurons in the ventral tegmental
area and other regions have been traditionally linked to
processing of signals for reward, it has become increas-
ingly clear that a portion of these cells also encode
aversive/punishment signals (29). Indeed, in our healthy
controls the responses in the ventral tegmental area to
all 3 experimental periods were compatible with the
encoding of signals of punishment and reward: activa-
tion during pain anticipation and pain stimulus, but
deactivation during relief anticipation. Furthermore,
responses in the ventral tegmental area during pain
anticipation were positively correlated with responses
during pain stimulation, and negatively correlated with
responses during relief anticipation (i.e., subjects with
greater activation in the ventral tegmental area during
pain anticipation had greater deactivation in the same
area during relief anticipation). In FM patients, how-
ever, responses in the ventral tegmental area to all
experimental periods were dramatically reduced or abol-
ished, and the activity during pain anticipation and relief
anticipation was not related.
Our observation that a region rich in dopaminer-
gic neurons, such as the ventral tegmental area, exhibits
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less reactivity to all experimental periods is compatible
with the results of other studies showing altered dopa-
minergic neurotransmission in FM patients. For in-
stance, recent PET studies have demonstrated that FM
patients exhibit reduced activity levels of DOPA decar-
boxylase, an enzyme involved in dopamine metabolism,
in several regions including the ventral tegmental area
(17). They also exhibit reduced dopaminergic brain
responses to evoked pain (4) compared to healthy
controls. Of note, PET studies in humans have revealed
that higher binding potential of D2/D3 ligands, poten-
tially indicative of lower levels of endogenous dopamine
release, is associated with higher pain sensitivity in
healthy adults as well as FM patients (4,30). Thus,
altered dopaminergic neurotransmission may, at least in
part, be an underlying factor for the noted hyperalgesia
in FM patients (31–33), as was also observed in the
present study (Figure 1).
Interestingly, lower responsiveness of the ventral
tegmental area and other “reward regions” to noxious
stimuli predicts lower opioid-induced analgesia in
healthy subjects (34). Thus, altered responses in the
ventral tegmental area to pain (as well as to pain
anticipation/relief anticipation) in FM might be reflec-
tive of neural mechanisms associated with the lack of
therapeutic efficacy of opioids in treating pain related to
FM (opioid use for management of pain in FM is not
recommended by any current guidelines [35–37]). Fur-
thermore, recent evidence suggests a strong link be-
tween corticostriatal circuitry and chronic pain (38).
This circuitry is under the modulatory control of dopa-
minergic midbrain nuclei including the ventral tegmen-
tal area, and therefore our study provides further sup-
port for the notion that dopaminergic neurotrasmission
plays a role in the pathology underlying pain disorders.
While up to 65% of neurons in the ventral
tegmental area are dopaminergic, a large portion of the
remaining neurons are -aminobutyric acid–releasing
(GABAergic) neurons (39). Recent studies have shown
that most ventral tegmental area GABAergic neurons
are excited by aversive stimuli, including noxious stimuli,
suggesting that these cells play a role in processing
signals for punishment (15,40). Notably, in the study by
Cohen et al (15), these neurons exhibited a small
increase in firing rate during the exposure to a condi-
tional cue immediately preceding an aversive stimulus,
and a larger increase in firing rate during receipt of the
aversive stimulus itself. This activity profile was very
similar to the responses we observed in the ventral
tegmental area in our controls. Since GABA levels are
diminished in some brain regions in FM patients (41), it
is possible that reduced GABAergic neurotransmission
also contributes to the group differences we observed in
brain activity. However, as no direct measure of GABA
or dopamine was obtained in this study, the neurochem-
ical correlates of our results are only speculative and will
need to be directly investigated.
One possible explanation for the between-group
differences in activity observed in other brain regions
during the pain anticipation/relief anticipation periods
involves the concept of salience (i.e., the ability of a
given stimulus to stand out from its background). As
most patients reported experiencing some amount of
ongoing pain (i.e., their clinical pain) even in the ab-
sence of cuff stimulation, the cues may have only sig-
naled the transition from a lower level of pain to a higher
level of pain (or vice versa), rather than the transition
from a pain-free state to a moderately strong pain state
(or vice versa), as was the case in the healthy controls. It
is therefore possible that the observed differences be-
tween the groups might partly reflect a lower salience
attributed by the patients to the impending onset or
offset of cuff pain stimulation. Since several of the
regions that were observed to be activated during the
pain anticipation/relief anticipation periods (including
the somatosensory, insular, cingulate, frontal, and pari-
etal areas) have been implicated in the detection of
salient changes in the sensory environment (42–44), our
data at least in part support this interpretation. More-
over, stimuli with high emotional salience induce stron-
ger activations of visual areas compared to less salient
stimuli (45). Therefore, the differences between the
groups with regard to visual cortex activation during
pain anticipation corroborate the notion of potential
differences in processing of salient events.
Furthermore, reduced brain responses to the
anticipation of pain relief were observed in regions that
are often implicated in placebo analgesia, including the
ventrolateral prefrontal cortex, dorsolateral prefrontal
cortex, and insula (46–48). Therefore, such results could
be partly explained by the expectation, in FM patients, of
a lower degree of pain relief, since, in their case, the end
of stimulus does not mean the end of pain perception
(i.e., their clinical pain continues).
Other factors might also contribute to the brain
activity differences we observed between groups, such as
the reduced ability of patients with FM to engage
pain-coping mechanisms. Among the regions that were
activated to a lesser degree during pain anticipation in
FM patients was the periaqueductal gray. The periaque-
ductal gray is a midbrain structure that has been impli-
cated in descending pain modulation by a large number
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of studies. For instance, electrical stimulation of sub-
regions of the periaqueductal gray in animals has been
shown to reduce behavioral responses to noxious stim-
ulation by inhibiting nociceptive dorsal horn neurons
indirectly through projections to the rostral ventrome-
dial medulla (49). Therefore, activation of the periaque-
ductal gray during expectancy of pain in healthy controls
may reflect the engagement of the descending pain
inhibitory mechanisms preparatory to the upcoming
pain stimulus. According to this view, the reduced
periaqueductal gray activation in FM patients would be
indicative of a reduced ability to engage such coping
mechanisms, a notion also supported by the results of
other studies (6).
Yet another mechanism potentially contributing
to reduced responsiveness in FM patients to the exper-
imental conditions may be related to perceived helpless-
ness. A recent study of a different chronic pain popula-
tion (temporomandibular disorder) has demonstrated
that there is a relationship between reported helpless-
ness and cortical thickness in the supplementary motor
area and midcingulate cortex (50). As these regions were
among those exhibiting lower responsiveness to pain
anticipation in FM patients in our study, future studies
should investigate whether catastrophizing-related fac-
tors such as helplessness and structural brain changes
may contribute to the explanation of our observations.
Several caveats should be taken into consider-
ation. First, we did not collect behavioral data that
directly measured perceived reward or punishment.
Thus, linking altered responses in the ventral tegmental
area in FM patients to alterations in the processing of
punishment and reward is only based on the well-
accepted role of this brain region in the processing of
aversive/rewarding stimuli, as well as on the assumption
that anticipating or perceiving a painful stimulus is a
punishing experience, while anticipating relief from pain
is a rewarding experience. Similarly, we did not collect
behavioral data allowing us to test the hypothesis that
experimental pain stimuli may be less salient for patients
because of the competing ongoing clinical pain. It is also
important to note that since FM patients were more
sensitive to pain stimuli, they required less pressure to
achieve the target pain sensation compared to the
healthy controls. Thus, we cannot exclude the idea that
the differences in the physical intensity of the stimula-
tion might explain at least part of the brain effects
observed in this study.
In summary, we demonstrated the existence in
FM patients of pain-related alterations within brain
circuitry associated with the processing of reward/
punishment and salience. Our results further support the
notion of a reduced ability to engage the descending
pain modulatory system in these patients. While we did
not directly investigate neurotransmitter release, our
observations are also compatible with results of previous
studies demonstrating altered dopaminergic/
GABAergic neurotransmission in FM patients. These
findings could contribute to our understanding of some
hallmarks of FM, including augmented central process-
ing of pain and the lack of therapeutic efficacy of opioid
treatments.
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